Searchable abstracts of presentations at key conferences in endocrinology

ea0034p234 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Expression of GLP1 receptors throughout the mouse brain using a novel transgenic mouse model

Cork Simon C , Reimann Frank , Gribble Fiona M , Trapp Stefan

Glucagon-like peptide 1 (GLP1) acts as both a peripheral incretin hormone and a central neuropeptide to regulate glucose and energy homeostasis. Within the brain, GLP1 is synthesised by a discrete collection of neurones in the brainstem, and presynaptic release of GLP1 results in binding to postsynaptic GLP1 receptors (GLP1R). The pattern of projections from these GLP1 synthesising neurones in the mouse brain has been described previously1,2. Here we use a novel tra...

ea0034p250 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Virally delivered target-specific optogenetic stimulation of PPG neurons in the nucleus of the solitary tract

Richards James E , Cork Simon C , Holt Marie , Reimann Frank , Gribble Fiona M , Trapp Stefan

Glucagon like peptide-1 (GLP-1) is derived from selective cleavage of the preproglucagon (PPG) molecule synthesised in intestinal L-cells. The physiological action of GLP-1 is most commonly recognised as a peripherally released incretin, but a subset of neurons in the lower brainstem, the PPG neurons, also express GLP-1. The majority of PPG neuronal cell bodies are located in the nucleus of the solitary tract and their axons project to numerous sites throughout the CNS. Many o...

ea0065oc2.4 | Neuroendocrinology, Pituitary and Neoplasia | SFEBES2019

Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression

Alonso Aldara Martin , Cork Simon C , Ma Yue , Herzog Herbert , Bloom Stephen R , Distaso Walter , Murphy Kevin G , Salem Victoria

Introduction: The gut hormone peptide YY 3-36 (PYY3-36) is secreted postprandially from intestinal L-cells to signal satiety. Peripheral administration of PYY3-36 suppresses food intake in rodents and humans. PYY3-36-based drugs are therefore promising anti-obesity treatments. It has been proposed that circulating PYY3-36 supresses appetite via the Y2 receptor (Y2R) in the hypothalamic arcuate nucleus (ARC). The vagus nerve, the majo...

ea0065p193 | Metabolism and Obesity | SFEBES2019

Modulation of vagal afferent signalling by the amino acid metabolite sensor GPR35

Roberts Anna , Cheng Sijing , Norton Mariana , Mohamed Omer , Cork Simon C , Salem Victoria , Hanyaloglu Aylin , Murphy Kevin

High dietary protein intake can suppress appetite, drive weight loss and improve glucose homeostasis. Understanding the mechanisms by which ingested protein is sensed may reveal new therapeutic targets for metabolic disease. G-protein coupled receptor 35 (GPR35) is activated by compounds including Kynurenic acid (Kyna), a product of amino acid metabolism. GPR35 is expressed in the intestines, most highly in the colon, and has recently been identified in the afferent vagus nerv...

ea0065p233 | Metabolism and Obesity | SFEBES2019

L-Phenylalanine simulates the secretion of pancreatic hormones via vagal CaSR

Norton Mariana , Cork Simon C , Roberts Anna , Patel Yateen , Cheng Sijing , Hansford Robert , Cao Ye , Hanyaloglu Aylin , Chang Wenhan , Murphy Kevin G

High protein diets are effective at promoting weight loss and stimulating the secretion of pancreatic hormones. Understanding the mechanisms underlying these effects may highlight new potential therapeutic targets. The calcium sensing receptor (CaSR) is stimulated by calcium and plays a critical role in calcium homeostasis. However, it is also found in many tissues unrelated to calcium regulation. CaSR activity can be modulated by aromatic amino acids, most potently by ...